Lucid Diagnostics Inc.
LUCD
$1.14
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.27M | -10.40M | -4.44M | -26.91M | -11.54M |
| Total Depreciation and Amortization | 209.00K | 220.00K | 222.00K | 221.00K | 222.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.52M | -24.00K | -5.62M | 15.58M | 494.00K |
| Change in Net Operating Assets | -45.00K | -692.00K | -709.00K | -1.36M | 954.00K |
| Cash from Operations | -12.58M | -10.89M | -10.55M | -12.47M | -9.87M |
| Capital Expenditure | -51.00K | -28.00K | -25.00K | -93.00K | -259.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -51.00K | -28.00K | -25.00K | -93.00K | -259.00K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 360.00K | 21.62M |
| Total Debt Repaid | -- | -- | -- | -- | -3.62M |
| Issuance of Common Stock | 2.00K | 27.13M | 16.46M | 15.08M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.00K | 27.13M | 16.46M | 15.44M | 18.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.63M | 16.21M | 5.89M | 2.88M | 7.87M |